George Marshall
Baker McKenzieBaker McKenzie’s equity capital markets team boasts notable strengths in handling equity transactions in emerging markets and is also increasingly active in advising UK issuers and underwriters on high-value offerings and private placements. The team is particularly well-versed in handling transactions in the life sciences and biotech sectors and regularly guides public companies in this space through IPOs, accelerated bookbuild offerings, and share buybacks. Practice head Adam Farlow is dual US- and UK-qualified lawyer and accordingly handles a diverse caseload of European listings and offerings subject to US securities regulations. George Marshall is noted for his experience handling equity transactions in Middle Eastern markets.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Baker McKenzie has a strong track-record in KSA ECM, where they have acted on a large number of IPOs. As a result, they have a very good view of the evolution of market practice and are able to provide advice and address issues in a timely manner.’
‘Strong team with insights into the key regional markets. Desire to grow the practice and therefore are available for general queries.’
‘George Marshall is a very strong lawyer, focused on details and technically very competent.’
‘George Marshall and Adam Farlow are proactive professionals with a strong commercial, can-do mindset. They were available at short notice for calls and helped solve tricky issues on auditor comfort.’
‘Broad capabilities across the world.’
‘Adam Farlow is practical, knowledgeable and able to resolve commercial points quickly and with finesse.’
‘The BM team is fully committed, always available to support, responsive, offers fast and reliable execution, delivers excellent quality, and is very knowledgeable from a technical perspective.’
‘They're experts in their field. Super methodical and very hard working.’
Key clients
- ABG Sundial Collier
- Al-Nahdi Medical Company
- Atomico III LP
- Barclays Bank Ireland PLC
- BNP Paribas
- Biocartis Group NV
- Carnegie Investment Bank AB (publ)
- Embracer Group
- Goldman Sachs
- HSBC
- Huuuge, Inc.
- Jadwa Industrial Investment Company
- Kempen
- Media and Games Invest plc
- Mithra Pharmaceuticals
- Olam International Group and Olam Food Ingredients (ofi)
- Pareto Securities
- Sequana Medical NV
- Turkven Private Equity
Work highlights
- Advised Huuuge Inc on a share buyback.
- Advised Olam Food Ingredients on a demerger and initial public offering.
- Advised Embracer on its primary issuance of shares of SEK 2bn, where the subscription price was determined through an accelerated book building procedure.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Adam Farlow